Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05932199
Title Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Baylor College of Medicine
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Baylor St Lukes Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field